This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
|Podcasts|February 19, 2021
S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH
Author(s)Lindsey Carr, Editor
On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.
Advertisement
Sheth is Associate Professor, Obstetrics, Gynecology and Reproductive Sciences; Associate Medical Director & Director of Colposcopy and Cervical Dysplasia, Women's Center, at Yale New Haven Hospital.
Advertisement
Related to this article
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Samples from a large UK screening trial supported validation of the investigational Evident ovarian cancer test, according to Dawn Mattoon, PhD.
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
Q&A: Soma Mandal, MD, MSCP, on FDA boxed warning removals for MHT
3
FAQ: How is off-label testosterone dosed and monitored in women?
4
Mental health, bias, and trauma: Building trust in sexual medicine
5